| Sep 28, 2011
| 2:37 AM
LONDON (Reuters) - Bloomsbury Publishing, home to the Harry Potter books in Britain, launched its first purely digital imprint on Wednesday which it said would bring out-of-print titles "back from the dead."
Bloomsbury Reader has signed up a string of...
| May 10, 2012
| 6:47 AM
HEXHAM, England — A bone-chilling rain swept over the moors on the October day we hiked to the top of the ruins of Hadrian's Wall, a few miles south of the Scottish border.
Gusts of wind, scouring the tumble-down ruins of the Second Century Roman...
| Dec 3, 2011
When Tasha Alexander strolls the streets of Chicago, she doesn't much see Wrigley Field or the Chicago River or Logan Square. Or Honda Civics.
She sees St. Paul's Cathedral and the River Thames and Belgrave Square and hansom cabs.
| May 13, 2012
"Prague Winter: A Personal Story of Remembrance and War, 1937-1948"
Harper: 480 pp., $29.99
Madeleine Albright is a formidable figure. She was a member of the National Security Council and the U.S. ambassador to the U.N. When she...
| Jun 30, 2012
| 6:10 PM
Saturday marked the end of the road to London for Katie Hoff, the former Towson-based swimmer who failed to match her dominating performance in the 2008 U.S. Olympic trials.
After failing to qualify in the 200- and 400-meter freestyle races earlier in...
| Aug 13, 2010
| 10:21 AM
Francesca Simon is an international star. Her series of children's books about Horrid Henry (Sourcebooks: $4.99 each, ages 8-12) have sold 14 million copies in 24 countries. In England, where she lives, "Horrid Henry and the Football Fiend" was No. 12...
| Oct 9, 2011
What's in a name? When it comes to nail polish, a catchy name can seal the deal for a woman searching for "her" color.
Flip the bottle to read the label and a quirky or funny name instantly sets a shade apart in a sea of reds, pinks and nudes —...
| Nov 4, 2011
| 11:46 AM
LONDON (Reuters) - Commercial weight-loss programs such as Weight Watchers and Slimming World are more effective and cheaper than family doctor-based services led by specially trained staff, according to the findings of a study published on Friday....
| Sep 7, 2011
| 9:15 AM
LONDON(Reuters) - Britain's health costs watchdog NICE has decided to back Japanese drugmaker Takeda's bone cancer drug Mepact after re-assessing the impact of a discount on the medicine for patients in the state-funded National Health Service (NHS).
| Nov 24, 2011
| 12:41 PM
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
The move underscores Gardasil's lead in a $1 billion-plus worldwide...
| May 30, 2012
| 8:27 AM
NEW YORK (Reuters Health) - Electronic health records have been held up as a way to improve medical care, but a new study suggests they are not necessarily making a difference in diabetes treatment.
The study, of 42 physician practices in two U.S....